MRT beim Tenosynovialen Riesenzelltumor (TGCT) – (früher Pigmentierte Villonoduläre Synovialitis – PVNS)

Marius Horger; Jan Fritz; Georg Gohla; Stefan Heckl

doi:10.1055/a-2655-2621

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Table of Contents

Rofo
DOI: 10.1055/a-2655-2621

Bildessay

MRT beim Tenosynovialen Riesenzelltumor (TGCT) – (früher Pigmentierte Villonoduläre Synovialitis – PVNS)

MRI in tenosynovial giant cell tumor (TGCT) – (formerly pigmented villonodular synovitis – PVNS)

Marius Horger

¹Department of Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen, Tübingen, Germany

,

Jan Fritz

²Radiology, New York University Medical Center, New York, United States (Ringgold ID: RIN12297)

,

Georg Gohla

³Department of Diagnostic and Interventional Neuroradiology, Eberhard Karls University Tübingen, Tübingen, Germany (Ringgold ID: RIN9188)

,

Stefan Heckl

⁴Department of Radiology, Hirslanden Park Hospital, Zürich, Switzerland (Ringgold ID: RIN60557)

› Author Affiliations

Abstract

Full Text

References

Literatur
1 de Saint Aubain Somerhausen N, van de Rijn M. WHO Classification of Tumours Editorial Board, Hrsg. Tenosynovial giant cell tumour. In: WHO Classification of Tumours, Soft Tissue and Bone Tumours. Lyon: International Agency for Research on Cancer; 2020: 133-136
2 de Saint Aubain Somerhausen N, van de Rijn M. Tenosynovial giant cell tumour, localized type. In: Fletcher CDM, Bridge JA, Hogendoorn P. et al. , Hrsg. WHO Classification of Tumours of Soft Tissue and Bone. Lyon: International Agency for Research on Cancer; 2013: 100-101
3 Lopez-Bastida J, Aranda-Reneo I, Rodríguez-Sánchez B. et al. Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry. Orphanet Journal of Rare Diseases 2021; 16: 294
4 Verspoor FGM, Zee AAG, Hannink G. et al. Long-term follow-up results of primary and recurrent pigmented villonodular synovitis. Rheumatology (Oxford) 2014; 53: 2063-2070
5 Murphey MD, Rhee JH, Lewis RB. et al. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics 2008; 28: 1493-1518
6 Cheng XG, You YH, Liu W. et al. MRI features of pigmented villonodular synovitis (PVNS). Clin Rheumatol 2004; 23: 31-34
7 Nishio J, Nakayama S, Koga K. et al. Giant Cell Tumor of Soft Tissue: An Updated Review. Journal of Clinical Medicine 2024; 13: 2870
8 West RB, Rubin BP, Miller MA. et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA 2006; 103: 690-695
9 Fiocco U, Sfriso P, Lunardi F. et al. Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis. Autoimmunity Reviews 2010; 9: 780-784
10 Kim D-E, Kim J-M, Lee B-S. et al. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints. Knee Surg Sports Traumatol Arthrosc 2018; 26: 3508-3514
11 Cosseddu F, Ipponi E, Ruinato AD. et al. Surgical management of villonodular-pigmented synovitis of knee: decisional algorithm. Orthop Rev (Pavia) 2022; 14: 39644